Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.

(Reuters) - Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon, a bookrunner said on Monday. The proposed sale will reduce the top shareholder's interest in Sensodyne-maker Haleon to 16.2% from 22.6%.

Haleon PLC, leading to a significant share repurchase.,UBS has reaffirmed its positive rating on Haleon following this development.,Haleon plans to cancel half of the repurchased shares as part of its